Clinical Trials Sponsored by Insmed Incorporated

Total 1697 results

GlycoMimetics Incorporated

Completed

A Study to Evaluate the Effect of IV Doses of GMI-1070 on Qtc Intervals in Healthy African-American Adult Subjects

Healthy

United States
GlycoMimetics Incorporated

Completed

A Study to Evaluate the Effect of IV Doses of Rivipansel on Subjects With Renal Impairment and in Healthy Subjects

Healthy | Renal Impairment

United States
GlycoMimetics Incorporated

Completed

Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis

Sickle Cell Disease | Vaso-occlusive Crisis | Pain Crisis

United States, Canada
GlycoMimetics Incorporated

Completed

A Study to Determine the Efficacy, Safety and Pharmacokinetics of GMI-1271 as Adjunct to Standard of Care for the Treatment of Multiple Myeloma

Multiple Myeloma

Ireland, Denmark, United Kingdom, Germany
Hollister Incorporated

Completed

Comparison of Two Intermittent Urinary Catheters

Urinary Retention

United States
Ingredion Incorporated

Completed

Effects of Fiber on Satiety

Obesity

United Kingdom
Hollister Incorporated

Completed

Assessment of an Endotracheal Tube Securement Device

Respiratory Insufficiency

United States
Hollister Incorporated

Terminated

Preliminary Evaluation of CASTLE Barrier Prototype UK

Peristomal Skin Complication

United Kingdom
Proacta, Incorporated

Terminated

A Dose Escalation Trial of PR610 Treating Patients With Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

New Zealand, United States
Lenstec Incorporated

Completed

Evaluation of Effective Lens Position With a Uniplanar Bi-aspheric IOL

Cataract

United States
Lenstec Incorporated

Completed

Lenstec Softec HD Posterior Chamber Intraocular Lens Clinical Investigational Protocol

Cataract
Genta Incorporated

Unknown

A Study of Tesetaxel Plus Capecitabine in Patients With Solid Tumors

Solid Tumor

United States
Genta Incorporated

Completed

Effects of Food on the Pharmacokinetics of Tesetaxel 10 mg Capsules

Solid Tumors

United States
Genta Incorporated

Completed

Genasense as a 2-hour Intravenous Infusion in Subjects With Solid Tumors

Solid Tumors

United States
Genta Incorporated

Unknown

Tesetaxel as Second-line Therapy for Patients With Advanced Gastric Cancer

Adenocarcinoma of the Stomach | Adenocarcinoma of Esophagogastric Junction

United States, Korea, Republic of
Genta Incorporated

Unknown

Tesetaxel Plus Capecitabine and Cisplatin in Advanced Gastric Cancer

Gastric Carcinoma

Korea, Republic of
Genta Incorporated

Completed

A Phase I, Randomized, Open-label, Cross-over, Pharmacokinetic Study of Genasense With and Without Dacarbazine

Advanced Melanoma
Genta Incorporated

Unknown

Abraxane and Temodar Plus Genasense in Advanced Melanoma

Melanoma

United States
Biosynexus Incorporated

Completed

Safety and Efficacy of Pagibaximab Injection in Very Low Birth Weight Neonates for Prevention of Staphylococcal Sepsis

Staphylococcal Sepsis

United States
Genta Incorporated

Completed

Phase I/II Study of Genasense in Patients With Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia | CLL

United States
Cook Group Incorporated
William Cook Europe; MED Institute, Incorporated; Cook Japan Incorporated

Completed

Evaluation of the Zilver PTX Drug-Eluting Stent in the Above-the-Knee Femoropopliteal Artery (Zilver PTX)

Peripheral Vascular Diseases

United States, Japan, Germany
Kevin Winthrop
The University of Texas Health Science Center at Tyler; Insmed Incorporated

Completed

Liposomal Amikacin for Inhalation (LAI) in the Treatment of Mycobacterium Abscessus Lung Disease

Mycobacterium Infections, Nontuberculous | Mycobacteria, Atypical

United States
InMed Pharmaceuticals Inc.

Completed

INM-755 (Cannabinol) Cream for Treatment of Epidermolysis Bullosa

Epidermolysis Bullosa Dystrophica | Epidermolysis Bullosa Simplex | Epidermolysis Bullosa, Junctional | Kindler Syndrome

France, Germany, Greece, Israel, Italy
ResMed

Recruiting

Post Market Clinical Follow up of ResMed Mask Systems

Obstructive Sleep Apnea

Australia
ResMed

Completed

Evaluating the Efficacy of PAP Therapy for Treating OSA in the Home Environment

Obstructive Sleep Apnea (OSA)

United States, Australia
ResMed

Completed

Evaluation of a Health Dashboard Intervention to Improve Engagement With CPAP Therapy in PAP-Naïve Patients: Project Neo

Sleep Apnea, Obstructive

Australia
ResMed

Completed

ApneaLink Air Home Sleep Testing (HST) Device Validation Study

Sleep-disordered Breathing

United States
ResMed

Completed

Usability Evaluation - Reassure Respiration Rate Device: Home User Study

Ease of Use
ResMed

Completed

Assessment of the Performance of a New Reduced Noise Mask Vent

Obstructive Sleep Apnoea (OSA)

Australia
ResMed

Completed

Usability of a Breathing-CBT Platform (CBT = Cognitive Behavioural Therapy)

Breathing, Mouth

Australia
ResMed

Completed

Comparison of Two Continuous Positive Airway Pressure Systems

Obstructive Sleep Apnoea

Australia
ResMed

Completed

Foam Mask - Assessment of Bioburden in a New Mask Seal Material

Obstructive Sleep Apnea (OSA)

Australia
ResMed

Completed

Analysis of a New Mask for Positive Airway Pressure (PAP) Device Users

Obstructive Sleep Apnea

Australia
ResMed

Withdrawn

Vent Flow Study of Prototype Nasal CPAP Mask (GVFECT)

Obstructive Sleep Apnea (OSA)
ResMed

Completed

Usability Evaluation of Menai CPAP Masks

Obstructive Sleep Apnea

Australia
ResMed

Completed

French Cohort Study of Chronic Heart Failure Patients With Central Sleep Apnoea Eligible for Adaptive Servo-Ventilation (PaceWave, AutoSet CS) (FACE)

Chronic Heart Failure | Central Sleep Apnea

France
ResMed

Completed

Evaluation of ApneaLink Plus Scoring Capabilities

Sleep Apnea, Obstructive | Sleep Apnea, Central

Germany
ResMed

Completed

SchlaHF-XT-Register. Sleep Disordered Breathing in Heart Failure Register

Heart Failure (HF)

Germany
ResMed

Completed

AutoSet for Her Quality of Life Clinical Trial (FEM-PAP)

Obstructive Sleep Apnea

Germany, Spain
ResMed

Terminated

A Study of Expiratory Pressure Modulation in Moderate to Severe COPD Patients - Phase 1b (ComfortCOPD)

Chronic Obstructive Pulmonary Disease

Germany
ResMed

Completed

Validation of the ApneaLink Sleep Screener for Obstructive Sleep Apnea (OSA)

Obstructive Sleep Apnea

United States
ResMed

Completed

Study of the Usability and Efficacy of a New Pediatric CPAP Mask

Respiratory Insufficiency | Obstructive Sleep Apnea

Australia
ResMed

Completed

Nasal Pillows vs. Nasal Masks at High CPAP Pressure

OSA

Australia
ResMed

Completed

The Evaluation of a New Sleep Algorithm

Healthy

Australia
ResMed

Completed

Evaluation of a Portable Device for Assessing Sleep Disordered Breathing in Congestive Heart Failure

Sleep Apnea Syndromes | Heart Failure, Congestive

Australia
ResMed

Recruiting

Long-term Benefits of CPAP or MAD Treatment on the Sleep of OSAS Patients (REMAP)

OSA

France
ResMed

Recruiting

Registry Study on Prescription, Patient Pathways, Therapy Efficacy and Usage of Mandibular Advancement Devices in Obstructive Sleep Apnea - PATT-OSA Registry (PATT-OSA)

Obstructive Sleep Apnea

Germany
ResMed

Completed

Oran Park Mask External Clinical Study (3) Marketing Claims Study

Obstructive Sleep Apnea

United States
ResMed

Completed

Personal Therapy Comfort Settings Pilot Clinical Study

Obstructive Sleep Apnea

Australia
ResMed

Completed

Evaluation of a Portable Oxygen Concentrator During Ambulation for Patients Who Require Supplemental Oxygen (POC-LEAN)

Chronic Obstructive Pulmonary Disease

United States

3

Subscribe